Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Zealand Pharma
Biotech
Zealand Pharma’s GLP-1/GLP-2 agonist tied to 8.3% weight loss
New findings for Zealand Pharma's weight loss candidate have emboldened the biotech to push the asset into a phase 2b trial.
Gabrielle Masson
Sep 10, 2024 10:45am
Takeda taps new head of US oncology business—Chutes & Ladders
Aug 2, 2024 8:30am
Zealand lines up Novo challenger as backbone weight loss therapy
Jun 21, 2024 5:30am
Zealand's dapiglutide shows little weight loss at lowest doses
May 24, 2024 5:14am
Boehringer shares more ph. 2 obesity data for Lilly, Novo rival
Jun 23, 2023 5:15pm
Boehringer posts slim slice of obesity data on Lilly, Novo rival
May 10, 2023 5:20am
